Evidence map›Paper›PMID 30026006›Full record

ArticleThe Journal of hospital infection2019

The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.

M J Zhou, J Li, H Salmasian, P Zachariah, Y-X Yang, D E Freedberg

Abstract read
In one paragraph

Article in The Journal of hospital infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M J ZhouDepartment of Medicine, Columbia University Medical Center, New York, NY, USA.
J LiBiomedical Informatics, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
H SalmasianData Science and Evaluation, Brigham and Women's Hospital, Boston, MA, USA.
P ZachariahDepartment of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Y-X YangDivision of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
D E FreedbergDivision of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY, USA. Electronic address: def2004@cumc.columbia.edu.

Funding

Loss of Gastrointestinal Colonization Resistance and Antibiotic-Resistant Infections in the Intensive Care UnitK23DK111847 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FREEDBERG, DANIEL E. · 2017 to 2020
$608k
NIDDK NIH HHS K23 DK111847
6 · The paper itself

Abstract

backgroundVancomycin-resistant enterococcus (VRE) causes 4% of all healthcare-associated infections in the USA. The process by which the local hospital milieu contributes to VRE acquisition is not fully understood.

aimTo determine the importance of specific factors within the local hospital environment for healthcare-associated VRE acquisition.

methodsThis retrospective cohort study included patients admitted to six intensive care units at an academic medical centre from January 2012 to December 2016 with negative rectal VRE cultures on admission. VRE acquisition was defined as a positive surveillance swab performed at any time after the initial negative swab during the index hospitalization. The exposures of interest were VRE colonization pressure, VRE importation pressure, and use of vancomycin. Multivariable Cox proportional hazards modelling was performed, with patients followed until VRE acquisition, death, or for up to 30 days.

findingsOf 8485 patients who were initially VRE negative, 161 patients acquired VRE. On univariate analysis, patients with VRE acquisition were more likely to have received vancomycin, to have had a neighbouring patient who received vancomycin, to have high VRE importation pressure, or to have high VRE colonization pressure. On multivariable analysis, only high VRE colonization pressure was an independent predictor of VRE acquisition (adjusted hazard ratio: 1.79; 95% confidence interval: 1.19-2.70).

conclusionVRE colonization pressure was the most important risk factor for healthcare-associated VRE acquisition, regardless of VRE importation pressure. Interventions seeking to reduce VRE acquisition should focus on minimizing transmission between patients with known VRE and the local hospital environment.

Indexed as

Academic Medical CentersAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsCross InfectionDisease Transmission, InfectiousDrug UtilizationFemaleGram-Positive Bacterial InfectionsHumansIntensive Care UnitsMaleMiddle AgedPrevalenceAnti-Bacterial AgentsVancomycinColonizationEnvironmentHealthcare-associated infectionHospitalVancomycin-resistant enterococcus

Identifiers

PMID30026006
PMCPMC6309650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.